Detalhe da pesquisa
1.
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
Medicina (Kaunas)
; 60(3)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38541156
2.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).
Eur J Haematol
; 110(6): 725-731, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941738
3.
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases.
Croat Med J
; 62(5): 455-463, 2021 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730885
4.
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
EClinicalMedicine
; 65: 102307, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033506
5.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases.
Hemasphere
; 6(12): e807, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36407092